---
schema_version: "secwatch.filing_event.v1"
accession: "0001757898-24-000001"
form_type: "8-K"
ticker: "STE"
cik: "0001757898"
company_name: "STERIS plc"
filed_at: "2024-02-07T23:59:59+00:00"
generated_at: "2026-06-06T07:08:59.194355+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# STERIS Q3 revenue rises 15% to $1.40B, adjusted EPS $2.22, outlook updated

## Summary
- Revenue $1.40B, +15% as reported; constant currency organic revenue +10%.
- Diluted EPS as reported $1.42; adjusted EPS $2.22.
- Fiscal 2024 outlook updated; no specific guidance figures provided in the release.

## SEC filing metadata
- accession: 0001757898-24-000001
- form_type: 8-K
- ticker: STE
- cik: 0001757898
- company_name: STERIS plc
- filed_at: 2024-02-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1757898/000175789824000001/0001757898-24-000001-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1757898/000175789824000001/ste-20240207.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001757898-24-000001
- JSON: https://secwatch.observer/filing/0001757898-24-000001.json
- Plain text: https://secwatch.observer/filing/0001757898-24-000001.txt

## Key facts
- Earnings Releases
  STERIS plc reported fiscal 2024 third quarter ended December 31, 2023 results: revenue $1.40 billion, EPS $1.42.
  - Period: fiscal 2024 third quarter ended December 31, 2023
  - Revenue: $1.40 billion
  - EPS: $1.42
  - Result: reported results
  source text: Revenue as reported for the quarter increased 15% to $1.40 billion compared with $1.22 billion in the third quarter of fiscal 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1757898/000175789824000001/0001757898-24-000001-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
